Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

Stopped early · Not applicable

Conditions studied: End Stage Renal Failure on Dialysis, Hyperplasia

In brief

The purpose of this study is to determine whether the long term use of the experimental Vascular Wrap(TM) Paclitaxel-Eluting Mesh is safe in the treatment of subjects needing hemodialysis access (via an expanded polytetrafluoroethylene (ePTFE) graft).

Key facts

Study ID
NCT01033357
Run by
Angiotech Pharmaceuticals
People needed
222
Starts
2008-03-01
Expected to finish
2010-10-01
Last updated by the study team
2013-02-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.